Theme: Expanding Present Vaccine Research Outcomes in the wake of Pandemic
Conference Chair Welcome Message:
On behalf of the Organizing Committee, it is our pleasure to welcome all participants to the Global Conference on Vaccines, Vaccines – 2021 to be held in Paris, France, August 26 – 28, 2021. Vaccines have taken center stage. The response to the COVID-19 pandemic has seen an unprecedented explosion in R&D, cooperation and collaboration. We see new ideas, new approaches and new vaccines. The global pace is breathtaking! We welcome all organizers, experts in the field, delegates, speakers and students. We especially encourage young researchers to present their recent research and to interact with other co-participants. Join us in Paris, the city of Louis Pasteur.
Let's enjoy the City of Lights and unique culture of Paris!!
About Conference:
The conference aims to empower future generations in different fields of Vaccinology to explore exciting research outcomes that lie in tune with the objectives and theme of this exciting event. It further helps you enhance your understanding of commercial, scientific and regulatory issues that affect strategic decision making in the Vaccine Sector.
This global conference sets the stage for brain-storming discussions among the participants with its enriching Q&A sessions, round table discussions and technical workshops and provides know-how of the latest methodologies and technicalities of Vaccines. Inspiring and educating talks from eminent scientists together with keynote lectures, plenary sessions, and video and poster presentations that span across the length and breadth of this conference.
We look forward to seeing you at Vaccines Conference-2021 in Paris, France.
Guidelines for the Abstract Submission:
1. The acceptable word range for the abstract is 150 – 250 words.
2. The abstracts which do not meet this word limit will be sent back to the author's to be revised.
3. The abstract content should be in English.
4. Please send with brief biography together with the Abstract.
5. Submit your abstract to (vaccines-2021@pagesconferences.com) mail Id.
6. After submission you will be acknowledged with the acceptance letter via an email within 2-3 working days.
Sumbmit Abstract Now Conference Gallery
CEO-Vetanco USA
Director-Max Planck Institute for Infection Biology, Germany
Head-Virology Agri-Food and Biosciences Institute United Kingdom
Research Director, National Institute of Health and Medical ResearchFrance
Scientist-Institute of Immunology and Experimental Therapy PAS Poland
Sechenov University Russia
Head-Zabludowicz Center for Autoimmune Diseases Israel
CEO & CSO - Verndari, Inc. USA
President & CEO-Human Vaccines Project New York
CEO-Food and Drugs Authority Accra - Ghana
GSK Vaccines Belgium
Head-Analytical R&D GSK Vaccines Belgium
GSK Vaccines Belgium
GSK Vaccines Belgium
Day 1 Schedule | |
---|---|
Time |
Session |
08:00 - 09:00 |
Registrations |
09:00 - 09:15 |
Opening Ceremony and Introduction |
09:15 - 11:00 |
Keynote Sessions |
11:00 - 11:20 |
Refreshments/Coffee Break |
11:20 - 13:00 |
Oral Presentations 1 |
13:00 - 14:00 |
Lunch with Table Discussions |
14:00 - 15:40 |
Oral Presentations 2 |
15:40 - 16:00 |
Refreshments/Coffee Break |
16:00 - 17:30 |
Oral Presentations 3 |
Day 2 Schedule | |
---|---|
Time |
Session |
09:30 - 11:00 |
Keynote Sessions |
11:00 - 11:20 |
Refreshments/Coffee Break |
11:20 - 13:00 |
Oral Presentations 4 |
13:00 - 14:00 |
Lunch with Table Discussions |
14:00 - 15:40 |
Oral Presentations 5 |
15:40 - 16:00 |
Refreshments/Coffee Break |
16:00 - 17:30 |
Poster Presentations |
Day 3 Schedule | |
---|---|
Time |
Session |
09:30 - 11:00 |
Keynote Sessions |
11:00 - 11:20 |
Refreshments/Coffee Break |
11:20 - 13:00 |
Oral Presentations 6 |
13:00 - 14:00 |
Lunch with Table Discussions |
14:00 - 15:40 |
Oral Presentations 7 |
15:40 - 16:00 |
Refreshments/Coffee Break |
16:00 - 17:30 |
Poster Presentations | End of Conference |
Join your peers at the event, it is the ultimate meeting place for all the experts worldwide for new interdisciplinary scientific collaborations and networking
Submit Abstract